These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8572738)

  • 21. CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.
    Planté-Bordeneuve V; Bandmann O; Wenning G; Quinn NP; Daniel SE; Harding AE
    Mov Disord; 1995 May; 10(3):277-8. PubMed ID: 7651442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotyping of the CYP2D6 gene in Norwegian lung cancer patients and controls.
    Tefre T; Daly AK; Armstrong M; Leathart JB; Idle JR; Brøgger A; Børresen AL
    Pharmacogenetics; 1994 Apr; 4(2):47-57. PubMed ID: 8081413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN).
    Atanasova SY; von Ahsen N; Toncheva DI; Dimitrov TG; Oellerich M; Armstrong VW
    Clin Biochem; 2005 Mar; 38(3):223-8. PubMed ID: 15708542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphism of debrisoquine oxidation: restriction fragment analysis and allele-specific amplification of mutant alleles of CYP2D6.
    Heim MH; Meyer UA
    Methods Enzymol; 1991; 206():173-83. PubMed ID: 1686063
    [No Abstract]   [Full Text] [Related]  

  • 25. Debrisoquin oxidation genotype and susceptibility to lung cancer.
    Agúndez JA; Martínez C; Ladero JM; Ledesma MC; Ramos JM; Martín R; Rodriguez A; Jara C; Benítez J
    Clin Pharmacol Ther; 1994 Jan; 55(1):10-4. PubMed ID: 8299311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci.
    Elexpuru-Camiruaga J; Buxton N; Kandula V; Dias PS; Campbell D; McIntosh J; Broome J; Jones P; Inskip A; Alldersea J
    Cancer Res; 1995 Oct; 55(19):4237-9. PubMed ID: 7671227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency of mutated allele CYP2D6*4 in the Turkish ankylosing spondylitis patients and healthy controls.
    Erden G; Acar FS; Inal EE; Soydas AO; Ozoran K; Bodur H; Yildirimkaya MM
    Rheumatol Int; 2009 Oct; 29(12):1431-4. PubMed ID: 19242697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.
    Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ
    Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis.
    Biały S; Iwaszko M; Świerkot J; Kolossa K; Wielińska J; Jeka S; Bogunia-Kubik K
    Immunol Res; 2024 Aug; 72(4):614-625. PubMed ID: 38714580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease.
    Planté-Bordeneuve V; Davis MB; Maraganore DM; Marsden CD; Harding AE
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):911-3. PubMed ID: 8057112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic susceptibility and the link between cat exposure and rheumatoid arthritis.
    Penglis PS; Bond C; Humphreys I; McCluskey J; Cleland LG
    Semin Arthritis Rheum; 2000 Oct; 30(2):111-20. PubMed ID: 11071582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis.
    Dahl ML; Johansson I; Bertilsson L; Ingelman-Sundberg M; Sjöqvist F
    J Pharmacol Exp Ther; 1995 Jul; 274(1):516-20. PubMed ID: 7616439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different Contributions of CDKAL1, KIF21B, and LRRK2/MUC19 Polymorphisms to SAPHO Syndrome, Rheumatoid Arthritis, Ankylosing Spondylitis, and Seronegative Spondyloarthropathy.
    Li N; Ma J; Li K; Guo C; Ming L
    Genet Test Mol Biomarkers; 2017 Feb; 21(2):122-126. PubMed ID: 27936930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An inactive cytochrome P450 CYP2D6 allele containing a deletion and a base substitution.
    Daly AK; Leathart JB; London SJ; Idle JR
    Hum Genet; 1995 Mar; 95(3):337-41. PubMed ID: 7868129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No association between familial Alzheimer disease and cytochrome P450 polymorphisms.
    Yamada H; Dahl ML; Viitanen M; Winblad B; Sjöqvist F; Lannfelt L
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):204-7. PubMed ID: 9772024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP2D6 genotype and lung cancer risk according to histologic type and tobacco exposure.
    Stücker I; Cosme J; Laurent P; Cenée S; Beaune P; Bignon J; Depierre A; Milleron B; Hémon D
    Carcinogenesis; 1995 Nov; 16(11):2759-64. PubMed ID: 7586196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP2D6 genotypes in Spanish women with breast cancer.
    Ladona MG; Abildúa RE; Ladero JM; Román JM; Plaza MA; Agúndez JA; Muñoz JJ; Benítez J
    Cancer Lett; 1996 Jan; 99(1):23-8. PubMed ID: 8564925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
    Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
    Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.